Marijuana has been employed since ancient times for the treatment of epilepsy. However, rigorous scientific data supporting its efficacy has been essentially nonexistent until recently.
In this video, Dr. Lazzara discusses a new study that identified patients at greatest risk of memory loss and global loss of cognitive function.
A new study makes the case for alternatives to opioids in the treatment of migraine.
Causes of concussion include direct trauma, rapid acceleration-deceleration, and blast injury. Dr. Wilner discusses recent literature.
A meta-analysis compared medical therapy with medical therapy plus angioplasty for the treatment of symptomatic vertebral artery stenosis.
An abstract presented at ACC 2017 explored the cardiovascular effects of cannabis use.
Blood protein analysis of plasma total tau has diagnostic use in Alzheimer disease. Could the same hold true for CTE?
Peter Goadsby, MD discusses the efficacy, safety, & tolerability of the CGRP inhibitor erenumab in a phase III trial of participants with episodic migraine.
Patients with Parkinson disease experiencing “off” episodes on levodopa/carbidopa now have another treatment option.
Is selective serotonin reuptake inhibitor use associated with an increased risk of spontaneous intracranial hemorrhage?